Immunotherapy of allergy: anergy, deletion, and immune deviation (Q56269909)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9914222%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

review article

1 reference

title

Immunotherapy of allergy: anergy, deletion, and immune deviation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9914222%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9914222%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

author name string

J Rolland

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9914222%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

publication date

1 December 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9914222%20AND%20SRC:MED&resulttype=core&format=json

Current Opinion in Immunology

9 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9914222%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9914222%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9914222%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

page(s)

640-645

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9914222%20AND%20SRC:MED&resulttype=core&format=json

The Specificity and Regulation of T-Cell Responsiveness to Allergens

9 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980082-4

7 January 2021

T cell response to grass pollen allergens: Correlation with skin test reactivity and serum IgE levels

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980082-4

7 January 2021

Allergen-driven limiting dilution analysis of human IL-4 and IFN-gamma production in allergic rhinitis and clinically tolerant individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980082-4

7 January 2021

Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980082-4

7 January 2021

Venom immunotherapy modulates interleukin-4 and interferon-gamma messenger RNA expression of peripheral T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980082-4

7 January 2021

Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980082-4

7 January 2021

Modulation of T-cell response to phospholipase A2 and phospholipase A2-derived peptides by conventional bee venom immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980082-4

7 January 2021

Bee venom immunotherapy induces a shift in cytokine responses from a TH-2 to a TH-1 dominant pattern: comparison of rush and conventional immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980082-4

7 January 2021

Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergen

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980082-4

7 January 2021

Decrease of allergen-specific T-cell response induced by local nasal immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980082-4

7 January 2021

Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980082-4

7 January 2021

House dust mite immunotherapy results in a decrease in Der p 2-specific IFN-gamma and IL-4 expression by circulating T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980082-4

7 January 2021

Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980082-4

7 January 2021

Activation of B-lymphocytes during pollen season. Effect of immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980082-4

7 January 2021

Peripheral deletion of antigen-reactive T cells in oral tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980082-4

7 January 2021

Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980082-4

7 January 2021

Clonal analysis of differential lymphokine production in peptide and superantigen induced T cell anergy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980082-4

7 January 2021

Role of interleukin 10 in specific immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980082-4

7 January 2021

The intensity of T cell receptor engagement determines the cytokine pattern of human allergen-specific T helper cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980082-4

7 January 2021

Interleukin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980082-4

7 January 2021

B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980082-4

7 January 2021

Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980082-4

7 January 2021

Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980082-4

7 January 2021

Increases in IL-12 messenger RNA+ cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980082-4

7 January 2021

Immunotherapy - anergy, deviation or suppression?

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980082-4

7 January 2021

Cytokines: Principles and prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980082-4

7 January 2021

Generation of Antigen-Specific Suppressor Cells during Allergy Desensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980082-4

7 January 2021

Rush immunotherapy results in allergen-specific alterations in lymphocyte function and interferon-gamma production in CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980082-4

7 January 2021

Human T and B cell immune responses to Fel d 1 in cat-allergic and non-cat-allergic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980082-4

7 January 2021

Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980082-4

7 January 2021

CD28 mRNA rapidly decays when activated T cells are functionally anergized with specific peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980082-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980082-4

1 reference

7 January 2021

Regulation of house dust mite responses by intranasally administered peptide: transient activation of CD4+ T cells precedes the development of tolerance in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980082-4

7 January 2021

Characterization of the specificity and duration of T cell tolerance to intranasally administered peptides in mice: a role for intramolecular epitope suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980082-4

7 January 2021

Induction of tolerance via the respiratory mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980082-4

7 January 2021

Modulation of the allergic immune response in BALB/c mice by subcutaneous injection of high doses of the dominant T cell epitope from the major birch pollen allergen Bet v 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980082-4

7 January 2021

Vaccination with a multi-epitopic recombinant allergen induces specific immune deviation via T-cell anergy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980082-4

7 January 2021

Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980082-4

7 January 2021

Effects of peptide therapy on ex vivo T-cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980082-4

7 January 2021

Antagonistic peptides specifically inhibit proliferation, cytokine production, CD40L expression, and help for IgE synthesis by Der p 1-specific human T-cell clones

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980082-4

7 January 2021

Recombinant allergens for immunotherapy: a Der p 2 variant with reduced IgE reactivity retains T-cell epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980082-4

7 January 2021

Bet v 1, the major birch pollen allergen, conjugated to crystalline bacterial cell surface proteins, expands allergen-specific T cells of the Th1/Th0 phenotype in vitro by induction of IL-12.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980082-4

7 January 2021

Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980082-4

7 January 2021

10.1016/S0952-7915(98)80082-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9914222%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference